| 貨號(hào) | 規(guī)格 | 價(jià)格 | 上海 | 北京 | 武漢 | 南京 | 購(gòu)買數(shù)量 |
|---|---|---|---|---|---|---|---|
S80905-5mg |
98.3% | ￥130.00 | 4 | - | - | - |
|
S80905-10mg |
98.3% | ￥220.00 | 9 | - | - | - |
|
S80905-25mg |
98.3% | ￥400.00 | 8 | - | - | - |
|
S80905-50mg |
98.3% | ￥620.00 | 5 | - | - | - |
|
S80905-100mg |
98.3% | ￥940.00 | 3 | - | - | - |
|
S80905-200mg |
≥98% | ￥1400.00 | 貨期：2-3天 | - | - | - |
|
Moclobemide (Ro111163) is a brain-penetrant and reversible monoamine oxidase (MAO-A) inhibitor with an IC50 of 6.061 μM for hMAO-A[1].Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice.
| 產(chǎn)品描述： | Moclobemide (Ro111163) is a brain-penetrant and reversible monoamine oxidase (MAO-A) inhibitor with an IC50 of 6.061 μM for hMAO-A[1].Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點(diǎn)： | MAO-A:6.061 (IC50);MAO;MonoamineOxidase | ||||||||||||||||||||
| 體內(nèi)研究： | Moclobemide is a monoamine oxidase inhibitor and increases the levels of brain monoamines (such as 5-HT, norepinephrine).Moclobemide(40 mg/kg) is effective in animal behavior models | ||||||||||||||||||||
| 參考文獻(xiàn)： | 1. Nafiz ?ncü Can, et al. Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity. Molecules. 2017 Aug 20;22(8):1381. 2. Yun-feng Li, et al. Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Acta Pharmacol Sin. 2004 Nov;25(11):1408-12. | ||||||||||||||||||||
| 溶解性： | DMSO : 100 mg/mL (372.11 mM; Need ultrasonic) | ||||||||||||||||||||
| 保存條件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號(hào)
危險(xiǎn)品化學(xué)品經(jīng)營(yíng)許可證（不帶存儲(chǔ)）
營(yíng)業(yè)執(zhí)照(三證合一)
掃一掃關(guān)注上海源葉微信公眾號(hào)
北京